Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples

Journal of Toxicologic Pathology - Japan
doi 10.1293/tox.23.213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Toxicologic Pathology

Related search

Drug-Induced Glucose Alterations Part 2: Drug-Induced Hyperglycemia

Diabetes Spectrum
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2014English

Successful Transplantation of Pediatric Kidneys Despite Vascular Injuries

Cureus
2018English

Adverse Drug Reactions

Anaesthesia
AnesthesiologyPain Medicine
2018English

Ex Vivo Metrics™, a Preclinical Tool in New Drug Development

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2008English

Utility of the Adverse Outcome Pathway Concept in Drug Development

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools

Current Drug Metabolism
Clinical BiochemistryPharmacology
2017English

Successful Non-Surgical Management of Bilateral Emphysematous Pyelonephritis Despite Adverse Prognostic Factors; Report of a Case and Review of the Literature

Journal of Nephropathology
Nephrology
2019English

Drug–drug–gene Interactions and Adverse Drug Reactions

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy